ArticleJournal of pharmacy & bioallied sciences2025
Enhancing Dengue Surveillance in Remote Tribal Communities of Chhattisgarh through Integrated Serological Diagnostics: An Observational Approach.
Article in Journal of pharmacy & bioallied sciences, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Dengue fever is a significant public health issue, affecting nearly 100 million people globally each year. Aim: This study investigates dengue infection trends, particularly focusing on thrombocytopenia and neurological symptoms in confirmed cases. Materials and Methods: A total of 1,558 blood samples were collected from probable dengue patients. Serological tests for NS1 antigen detection and IgM/IgG antibody titers were performed using enzyme-linked immunosorbent assay (ELISA). Results: In total, 166 samples (10.65%) out of 1,558 tested positive for dengue. IgM showed the highest positivity (40.47%), followed by NS1 antigen (37.5%). Males were more frequently affected than females, with a male-to-female ratio of 1.8:1. The age group of 21-30 years accounted for the largest number of cases (32.14%). Thrombocytopenia was observed in 88.09% of dengue-positive cases, with 26.19% having platelet counts below 50,000 cells/cumm. A few pediatric patients displayed severe neurological complications, including encephalitis, meningitis, and encephalopathy. Conclusion: This study highlights the importance of using IgG/IgM ratios to differentiate primary from secondary dengue infections; in addition, to control the severity of the disease, regular thrombocyte measurement is required and is highly recommended.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.